Cognivia

Cognivia

Developing predictive tools to de-risk clinical drug development

Founded 2013 Belgium

Belgium 26 employees Venture round Total: $19.50M Biotechnology, Health Care +2

Cognivia is a Belgium-based startup with a clear mission encapsulated in its slogan, "Developing predictive tools to de-risk clinical drug development." Founded in 2013, Cognivia stands out as an innovator in the Biotechnology, Health Care, and Information Technology industries. The company's proprietary analytical tools aim to optimize and accelerate the clinical development of new medicines. With a focus on mitigating risk and increasing clinical trial success, Cognivia has distinguished itself by offering Placebell©™, a solution that addresses the challenge of the placebo effect in clinical trials. This specialized solution has demonstrated the capability to improve clinical trial assay sensitivity by characterizing and managing individual placebo responses in various disease states. In the latest funding round on 18 April 2024, Cognivia secured a substantial €15.50M Venture Round investment from notable investors including Vesalius Biocapital, SFPIM, and WE International. This injection of capital symbolizes a strong vote of confidence in Cognivia's innovative approach and its potential impact on the pharmaceutical industry. Cognivia's ability to reduce the variability of study data by 30%, resulting in a decreased need for patients in trials and subsequently reduced time and cost, underscores the potential for significant industry disruption and enhanced efficiency. With a dedicated team of experienced pharmaceutical industry professionals at its helm, Cognivia is poised to be a noteworthy player in advancing the drug development landscape.

Funding Stage	Amount	Investors	Lead Investors	Date
Venture Round	€15.50M	3	Vesalius Biocapital, SFPIM +1	18 Apr 2024
Series B	€4.00M	4	Sambrinvest, the Innovation Fund +2	16 May 2019

Funding Stage

Amount

Investors

Lead Investors

Date

Venture Round

€15.50M

Vesalius Biocapital, SFPIM +1

18 Apr 2024

Series B

€4.00M

Sambrinvest, the Innovation Fund +2

16 May 2019

FAQ About Cognivia

Developing predictive tools to de-risk clinical drug development

Cognivia was founded in 2013.

Cognivia is headquartered in Belgium.

Cognivia operates in Biotechnology, Health Care, Health and Wellness and Information Technology. Its work centres on Clinical drug development, Pharmaceutical industry, Predictive tools and Analytical tools.

Cognivia has approximately 26 employees.

Cognivia has completed 2 funding rounds, raising a total of $19.50M. The latest funding stage is Venture round.

Top alternatives and competitors to Cognivia include ClinCloud Ltd., EXCIVA GmbH, Cancer Prevention Pharmaceuticals, Inc, Koneksa, MMS. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Cognivia and ClinCloud Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

What changed at Cognivia recently?

About Cognivia

Funding Rounds & Investors (2)

Cognivia Alternatives & Competitors

FAQ About Cognivia